nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—LHCGR—connective tissue—systemic lupus erythematosus	0.0055	0.391	CbGeAlD
Goserelin—LHCGR—kidney—systemic lupus erythematosus	0.00468	0.333	CbGeAlD
Goserelin—GNRHR—nervous system—systemic lupus erythematosus	0.00198	0.141	CbGeAlD
Goserelin—GNRHR—central nervous system—systemic lupus erythematosus	0.00191	0.136	CbGeAlD
Goserelin—LHCGR—Ovarian Infertility Genes—VDR—systemic lupus erythematosus	0.00103	0.0922	CbGpPWpGaD
Goserelin—LHCGR—Ovarian Infertility Genes—CDKN1B—systemic lupus erythematosus	0.000534	0.0479	CbGpPWpGaD
Goserelin—LHCGR—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.000463	0.0415	CbGpPWpGaD
Goserelin—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000404	0.000414	CcSEcCtD
Goserelin—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	0.000402	0.000413	CcSEcCtD
Goserelin—Pharyngitis—Methotrexate—systemic lupus erythematosus	0.000402	0.000413	CcSEcCtD
Goserelin—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000402	0.000412	CcSEcCtD
Goserelin—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000402	0.000412	CcSEcCtD
Goserelin—Nausea—Leflunomide—systemic lupus erythematosus	0.000401	0.000411	CcSEcCtD
Goserelin—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	0.0004	0.000411	CcSEcCtD
Goserelin—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000399	0.000409	CcSEcCtD
Goserelin—Vision blurred—Prednisone—systemic lupus erythematosus	0.000398	0.000408	CcSEcCtD
Goserelin—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000397	0.000407	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000397	0.000407	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000396	0.000407	CcSEcCtD
Goserelin—Pain—Hydrocortisone—systemic lupus erythematosus	0.000396	0.000406	CcSEcCtD
Goserelin—Oedema—Dexamethasone—systemic lupus erythematosus	0.000396	0.000406	CcSEcCtD
Goserelin—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	0.000396	0.000406	CcSEcCtD
Goserelin—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	0.000396	0.000406	CcSEcCtD
Goserelin—Oedema—Betamethasone—systemic lupus erythematosus	0.000396	0.000406	CcSEcCtD
Goserelin—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000394	0.000404	CcSEcCtD
Goserelin—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000393	0.000404	CcSEcCtD
Goserelin—Infection—Dexamethasone—systemic lupus erythematosus	0.000393	0.000403	CcSEcCtD
Goserelin—Infection—Betamethasone—systemic lupus erythematosus	0.000393	0.000403	CcSEcCtD
Goserelin—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000392	0.000402	CcSEcCtD
Goserelin—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.000391	0.000402	CcSEcCtD
Goserelin—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000391	0.000401	CcSEcCtD
Goserelin—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.000391	0.000401	CcSEcCtD
Goserelin—Anaemia—Prednisone—systemic lupus erythematosus	0.00039	0.0004	CcSEcCtD
Goserelin—Shock—Dexamethasone—systemic lupus erythematosus	0.000389	0.000399	CcSEcCtD
Goserelin—Shock—Betamethasone—systemic lupus erythematosus	0.000389	0.000399	CcSEcCtD
Goserelin—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000389	0.000399	CcSEcCtD
Goserelin—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000388	0.000398	CcSEcCtD
Goserelin—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000388	0.000398	CcSEcCtD
Goserelin—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000387	0.000397	CcSEcCtD
Goserelin—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000387	0.000397	CcSEcCtD
Goserelin—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000386	0.000396	CcSEcCtD
Goserelin—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000386	0.000396	CcSEcCtD
Goserelin—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000384	0.000394	CcSEcCtD
Goserelin—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000384	0.000394	CcSEcCtD
Goserelin—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000383	0.000393	CcSEcCtD
Goserelin—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000382	0.000392	CcSEcCtD
Goserelin—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000382	0.000392	CcSEcCtD
Goserelin—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000382	0.000391	CcSEcCtD
Goserelin—Malaise—Prednisone—systemic lupus erythematosus	0.000381	0.00039	CcSEcCtD
Goserelin—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000379	0.000388	CcSEcCtD
Goserelin—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000379	0.000388	CcSEcCtD
Goserelin—Anorexia—Betamethasone—systemic lupus erythematosus	0.000377	0.000387	CcSEcCtD
Goserelin—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000377	0.000387	CcSEcCtD
Goserelin—Urticaria—Prednisolone—systemic lupus erythematosus	0.000377	0.000386	CcSEcCtD
Goserelin—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000376	0.000386	CcSEcCtD
Goserelin—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000376	0.000386	CcSEcCtD
Goserelin—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000375	0.000385	CcSEcCtD
Goserelin—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000374	0.000384	CcSEcCtD
Goserelin—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000374	0.000383	CcSEcCtD
Goserelin—Pain—Triamcinolone—systemic lupus erythematosus	0.000373	0.000382	CcSEcCtD
Goserelin—Hypotension—Dexamethasone—systemic lupus erythematosus	0.00037	0.000379	CcSEcCtD
Goserelin—Hypotension—Betamethasone—systemic lupus erythematosus	0.00037	0.000379	CcSEcCtD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—P2RY12—systemic lupus erythematosus	0.00037	0.0331	CbGpPWpGaD
Goserelin—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000369	0.000378	CcSEcCtD
Goserelin—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000368	0.000377	CcSEcCtD
Goserelin—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000368	0.000377	CcSEcCtD
Goserelin—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000366	0.000375	CcSEcCtD
Goserelin—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000366	0.000375	CcSEcCtD
Goserelin—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000366	0.000375	CcSEcCtD
Goserelin—Convulsion—Prednisone—systemic lupus erythematosus	0.000366	0.000375	CcSEcCtD
Goserelin—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000365	0.000374	CcSEcCtD
Goserelin—Hypertension—Prednisone—systemic lupus erythematosus	0.000364	0.000374	CcSEcCtD
Goserelin—Chills—Methotrexate—systemic lupus erythematosus	0.000364	0.000373	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.00036	0.00037	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.00036	0.00037	CcSEcCtD
Goserelin—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.00036	0.000369	CcSEcCtD
Goserelin—Arthralgia—Prednisone—systemic lupus erythematosus	0.000359	0.000369	CcSEcCtD
Goserelin—Myalgia—Prednisone—systemic lupus erythematosus	0.000359	0.000369	CcSEcCtD
Goserelin—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000359	0.000369	CcSEcCtD
Goserelin—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000358	0.000368	CcSEcCtD
Goserelin—Anxiety—Prednisone—systemic lupus erythematosus	0.000358	0.000367	CcSEcCtD
Goserelin—Alopecia—Methotrexate—systemic lupus erythematosus	0.000358	0.000367	CcSEcCtD
Goserelin—Insomnia—Betamethasone—systemic lupus erythematosus	0.000358	0.000367	CcSEcCtD
Goserelin—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000358	0.000367	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000357	0.000366	CcSEcCtD
Goserelin—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000356	0.000366	CcSEcCtD
Goserelin—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000356	0.000365	CcSEcCtD
Goserelin—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000355	0.000364	CcSEcCtD
Goserelin—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000355	0.000364	CcSEcCtD
Goserelin—Discomfort—Prednisone—systemic lupus erythematosus	0.000355	0.000364	CcSEcCtD
Goserelin—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000355	0.000364	CcSEcCtD
Goserelin—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000353	0.000362	CcSEcCtD
Goserelin—Erythema—Methotrexate—systemic lupus erythematosus	0.000353	0.000362	CcSEcCtD
Goserelin—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000349	0.000358	CcSEcCtD
Goserelin—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000348	0.000357	CcSEcCtD
Goserelin—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000348	0.000357	CcSEcCtD
Goserelin—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000348	0.000357	CcSEcCtD
Goserelin—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000346	0.000355	CcSEcCtD
Goserelin—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000346	0.000354	CcSEcCtD
Goserelin—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000345	0.000354	CcSEcCtD
Goserelin—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000344	0.000353	CcSEcCtD
Goserelin—Anaphylactic shock—Prednisone—systemic lupus erythematosus	0.000344	0.000353	CcSEcCtD
Goserelin—Oedema—Prednisone—systemic lupus erythematosus	0.000344	0.000353	CcSEcCtD
Goserelin—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000344	0.000353	CcSEcCtD
Goserelin—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000344	0.000353	CcSEcCtD
Goserelin—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000344	0.000353	CcSEcCtD
Goserelin—Infection—Prednisone—systemic lupus erythematosus	0.000342	0.000351	CcSEcCtD
Goserelin—Back pain—Methotrexate—systemic lupus erythematosus	0.000341	0.00035	CcSEcCtD
Goserelin—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000341	0.00035	CcSEcCtD
Goserelin—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000341	0.00035	CcSEcCtD
Goserelin—Fatigue—Betamethasone—systemic lupus erythematosus	0.000341	0.00035	CcSEcCtD
Goserelin—Shock—Prednisone—systemic lupus erythematosus	0.000339	0.000348	CcSEcCtD
Goserelin—Pain—Betamethasone—systemic lupus erythematosus	0.000338	0.000347	CcSEcCtD
Goserelin—Pain—Dexamethasone—systemic lupus erythematosus	0.000338	0.000347	CcSEcCtD
Goserelin—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000338	0.000347	CcSEcCtD
Goserelin—Tachycardia—Prednisone—systemic lupus erythematosus	0.000336	0.000345	CcSEcCtD
Goserelin—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000336	0.000345	CcSEcCtD
Goserelin—Skin disorder—Prednisone—systemic lupus erythematosus	0.000335	0.000343	CcSEcCtD
Goserelin—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000333	0.000342	CcSEcCtD
Goserelin—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000332	0.000341	CcSEcCtD
Goserelin—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000332	0.000341	CcSEcCtD
Goserelin—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000331	0.00034	CcSEcCtD
Goserelin—Rash—Cyclosporine—systemic lupus erythematosus	0.000328	0.000337	CcSEcCtD
Goserelin—Anorexia—Prednisone—systemic lupus erythematosus	0.000328	0.000337	CcSEcCtD
Goserelin—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000328	0.000337	CcSEcCtD
Goserelin—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000328	0.000336	CcSEcCtD
Goserelin—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000327	0.000336	CcSEcCtD
Goserelin—Headache—Cyclosporine—systemic lupus erythematosus	0.000326	0.000335	CcSEcCtD
Goserelin—Anaemia—Methotrexate—systemic lupus erythematosus	0.000326	0.000334	CcSEcCtD
Goserelin—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000326	0.000334	CcSEcCtD
Goserelin—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000326	0.000334	CcSEcCtD
Goserelin—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000323	0.000332	CcSEcCtD
Goserelin—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000323	0.000332	CcSEcCtD
Goserelin—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000323	0.000331	CcSEcCtD
Goserelin—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000321	0.000329	CcSEcCtD
Goserelin—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.00032	0.000329	CcSEcCtD
Goserelin—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.00032	0.000329	CcSEcCtD
Goserelin—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.00032	0.000328	CcSEcCtD
Goserelin—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000318	0.000327	CcSEcCtD
Goserelin—Malaise—Methotrexate—systemic lupus erythematosus	0.000318	0.000326	CcSEcCtD
Goserelin—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000317	0.000325	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.000317	0.0284	CbGpPWpGaD
Goserelin—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000316	0.000324	CcSEcCtD
Goserelin—Urticaria—Betamethasone—systemic lupus erythematosus	0.000314	0.000322	CcSEcCtD
Goserelin—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000314	0.000322	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000314	0.000322	CcSEcCtD
Goserelin—Dizziness—Prednisolone—systemic lupus erythematosus	0.000313	0.000322	CcSEcCtD
Goserelin—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000313	0.000321	CcSEcCtD
Goserelin—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000313	0.000321	CcSEcCtD
Goserelin—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000313	0.000321	CcSEcCtD
Goserelin—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000313	0.000321	CcSEcCtD
Goserelin—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000313	0.000321	CcSEcCtD
Goserelin—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000312	0.00032	CcSEcCtD
Goserelin—Insomnia—Prednisone—systemic lupus erythematosus	0.000312	0.00032	CcSEcCtD
Goserelin—GNRHR—Peptide GPCRs—CCR5—systemic lupus erythematosus	0.00031	0.0278	CbGpPWpGaD
Goserelin—Nausea—Cyclosporine—systemic lupus erythematosus	0.000309	0.000317	CcSEcCtD
Goserelin—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000309	0.000317	CcSEcCtD
Goserelin—Pruritus—Triamcinolone—systemic lupus erythematosus	0.000308	0.000316	CcSEcCtD
Goserelin—Cough—Methotrexate—systemic lupus erythematosus	0.000308	0.000316	CcSEcCtD
Goserelin—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.000308	0.000316	CcSEcCtD
Goserelin—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000306	0.000314	CcSEcCtD
Goserelin—Convulsion—Methotrexate—systemic lupus erythematosus	0.000306	0.000314	CcSEcCtD
Goserelin—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000303	0.000311	CcSEcCtD
Goserelin—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000302	0.00031	CcSEcCtD
Goserelin—Arthralgia—Methotrexate—systemic lupus erythematosus	0.0003	0.000308	CcSEcCtD
Goserelin—Myalgia—Methotrexate—systemic lupus erythematosus	0.0003	0.000308	CcSEcCtD
Goserelin—Chest pain—Methotrexate—systemic lupus erythematosus	0.0003	0.000308	CcSEcCtD
Goserelin—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000299	0.000307	CcSEcCtD
Goserelin—Rash—Prednisolone—systemic lupus erythematosus	0.000299	0.000307	CcSEcCtD
Goserelin—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000299	0.000306	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000298	0.000306	CcSEcCtD
Goserelin—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000298	0.000305	CcSEcCtD
Goserelin—Fatigue—Prednisone—systemic lupus erythematosus	0.000297	0.000305	CcSEcCtD
Goserelin—Headache—Prednisolone—systemic lupus erythematosus	0.000297	0.000305	CcSEcCtD
Goserelin—Discomfort—Methotrexate—systemic lupus erythematosus	0.000297	0.000304	CcSEcCtD
Goserelin—Constipation—Prednisone—systemic lupus erythematosus	0.000295	0.000302	CcSEcCtD
Goserelin—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000294	0.000302	CcSEcCtD
Goserelin—Rash—Hydrocortisone—systemic lupus erythematosus	0.000292	0.000299	CcSEcCtD
Goserelin—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000292	0.000299	CcSEcCtD
Goserelin—Confusional state—Methotrexate—systemic lupus erythematosus	0.00029	0.000298	CcSEcCtD
Goserelin—Headache—Hydrocortisone—systemic lupus erythematosus	0.00029	0.000298	CcSEcCtD
Goserelin—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000288	0.000296	CcSEcCtD
Goserelin—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	0.000288	0.000295	CcSEcCtD
Goserelin—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000288	0.000295	CcSEcCtD
Goserelin—Infection—Methotrexate—systemic lupus erythematosus	0.000286	0.000293	CcSEcCtD
Goserelin—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000284	0.000291	CcSEcCtD
Goserelin—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000284	0.000291	CcSEcCtD
Goserelin—Asthenia—Betamethasone—systemic lupus erythematosus	0.000284	0.000291	CcSEcCtD
Goserelin—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000282	0.00029	CcSEcCtD
Goserelin—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000282	0.000289	CcSEcCtD
Goserelin—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000282	0.000289	CcSEcCtD
Goserelin—Nausea—Prednisolone—systemic lupus erythematosus	0.000282	0.000289	CcSEcCtD
Goserelin—Pruritus—Betamethasone—systemic lupus erythematosus	0.00028	0.000287	CcSEcCtD
Goserelin—Pruritus—Dexamethasone—systemic lupus erythematosus	0.00028	0.000287	CcSEcCtD
Goserelin—Skin disorder—Methotrexate—systemic lupus erythematosus	0.00028	0.000287	CcSEcCtD
Goserelin—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	0.000278	0.000286	CcSEcCtD
Goserelin—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000277	0.000284	CcSEcCtD
Goserelin—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000277	0.000284	CcSEcCtD
Goserelin—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000275	0.000282	CcSEcCtD
Goserelin—Rash—Triamcinolone—systemic lupus erythematosus	0.000275	0.000282	CcSEcCtD
Goserelin—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000275	0.000282	CcSEcCtD
Goserelin—Anorexia—Methotrexate—systemic lupus erythematosus	0.000274	0.000282	CcSEcCtD
Goserelin—Rash—Methylprednisolone—systemic lupus erythematosus	0.000274	0.000281	CcSEcCtD
Goserelin—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000274	0.000281	CcSEcCtD
Goserelin—Urticaria—Prednisone—systemic lupus erythematosus	0.000274	0.000281	CcSEcCtD
Goserelin—Headache—Triamcinolone—systemic lupus erythematosus	0.000273	0.00028	CcSEcCtD
Goserelin—Headache—Methylprednisolone—systemic lupus erythematosus	0.000272	0.00028	CcSEcCtD
Goserelin—Abdominal pain—Prednisone—systemic lupus erythematosus	0.000272	0.000279	CcSEcCtD
Goserelin—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000272	0.000279	CcSEcCtD
Goserelin—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000271	0.000278	CcSEcCtD
Goserelin—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000271	0.000278	CcSEcCtD
Goserelin—Hypotension—Methotrexate—systemic lupus erythematosus	0.000269	0.000276	CcSEcCtD
Goserelin—GNRHR—GPCRs, Other—CCR5—systemic lupus erythematosus	0.000263	0.0235	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000262	0.000269	CcSEcCtD
Goserelin—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000262	0.000268	CcSEcCtD
Goserelin—Dizziness—Betamethasone—systemic lupus erythematosus	0.000262	0.000268	CcSEcCtD
Goserelin—Insomnia—Methotrexate—systemic lupus erythematosus	0.00026	0.000267	CcSEcCtD
Goserelin—Nausea—Triamcinolone—systemic lupus erythematosus	0.000259	0.000266	CcSEcCtD
Goserelin—Paraesthesia—Methotrexate—systemic lupus erythematosus	0.000259	0.000265	CcSEcCtD
Goserelin—Nausea—Methylprednisolone—systemic lupus erythematosus	0.000258	0.000265	CcSEcCtD
Goserelin—Dyspnoea—Methotrexate—systemic lupus erythematosus	0.000257	0.000263	CcSEcCtD
Goserelin—Somnolence—Methotrexate—systemic lupus erythematosus	0.000256	0.000263	CcSEcCtD
Goserelin—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000254	0.00026	CcSEcCtD
Goserelin—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000253	0.00026	CcSEcCtD
Goserelin—Vomiting—Betamethasone—systemic lupus erythematosus	0.000251	0.000258	CcSEcCtD
Goserelin—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000251	0.000258	CcSEcCtD
Goserelin—Decreased appetite—Methotrexate—systemic lupus erythematosus	0.00025	0.000257	CcSEcCtD
Goserelin—Rash—Dexamethasone—systemic lupus erythematosus	0.000249	0.000256	CcSEcCtD
Goserelin—Rash—Betamethasone—systemic lupus erythematosus	0.000249	0.000256	CcSEcCtD
Goserelin—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000249	0.000256	CcSEcCtD
Goserelin—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000249	0.000256	CcSEcCtD
Goserelin—Fatigue—Methotrexate—systemic lupus erythematosus	0.000248	0.000255	CcSEcCtD
Goserelin—Headache—Dexamethasone—systemic lupus erythematosus	0.000248	0.000254	CcSEcCtD
Goserelin—Headache—Betamethasone—systemic lupus erythematosus	0.000248	0.000254	CcSEcCtD
Goserelin—Asthenia—Prednisone—systemic lupus erythematosus	0.000247	0.000254	CcSEcCtD
Goserelin—Pain—Methotrexate—systemic lupus erythematosus	0.000246	0.000253	CcSEcCtD
Goserelin—Pruritus—Prednisone—systemic lupus erythematosus	0.000244	0.00025	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000241	0.0216	CbGpPWpGaD
Goserelin—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000237	0.000243	CcSEcCtD
Goserelin—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000236	0.000242	CcSEcCtD
Goserelin—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	0.000235	0.000242	CcSEcCtD
Goserelin—Nausea—Betamethasone—systemic lupus erythematosus	0.000235	0.000241	CcSEcCtD
Goserelin—Nausea—Dexamethasone—systemic lupus erythematosus	0.000235	0.000241	CcSEcCtD
Goserelin—Urticaria—Methotrexate—systemic lupus erythematosus	0.000229	0.000235	CcSEcCtD
Goserelin—Dizziness—Prednisone—systemic lupus erythematosus	0.000228	0.000234	CcSEcCtD
Goserelin—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000228	0.000233	CcSEcCtD
Goserelin—Abdominal pain—Methotrexate—systemic lupus erythematosus	0.000228	0.000233	CcSEcCtD
Goserelin—Vomiting—Prednisone—systemic lupus erythematosus	0.000219	0.000225	CcSEcCtD
Goserelin—Rash—Prednisone—systemic lupus erythematosus	0.000217	0.000223	CcSEcCtD
Goserelin—Dermatitis—Prednisone—systemic lupus erythematosus	0.000217	0.000223	CcSEcCtD
Goserelin—Headache—Prednisone—systemic lupus erythematosus	0.000216	0.000221	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000213	0.0191	CbGpPWpGaD
Goserelin—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000212	0.000218	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—P2RY12—systemic lupus erythematosus	0.000212	0.019	CbGpPWpGaD
Goserelin—Asthenia—Methotrexate—systemic lupus erythematosus	0.000207	0.000212	CcSEcCtD
Goserelin—Nausea—Prednisone—systemic lupus erythematosus	0.000205	0.00021	CcSEcCtD
Goserelin—Pruritus—Methotrexate—systemic lupus erythematosus	0.000204	0.000209	CcSEcCtD
Goserelin—GNRHR—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000201	0.018	CbGpPWpGaD
Goserelin—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.000197	0.000202	CcSEcCtD
Goserelin—Dizziness—Methotrexate—systemic lupus erythematosus	0.00019	0.000195	CcSEcCtD
Goserelin—Vomiting—Methotrexate—systemic lupus erythematosus	0.000183	0.000188	CcSEcCtD
Goserelin—Rash—Methotrexate—systemic lupus erythematosus	0.000182	0.000186	CcSEcCtD
Goserelin—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000181	0.000186	CcSEcCtD
Goserelin—Headache—Methotrexate—systemic lupus erythematosus	0.00018	0.000185	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.00018	0.0161	CbGpPWpGaD
Goserelin—Nausea—Methotrexate—systemic lupus erythematosus	0.000171	0.000175	CcSEcCtD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.00017	0.0153	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000162	0.0145	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000161	0.0145	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000146	0.0131	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000143	0.0128	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000143	0.0128	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.000139	0.0125	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000136	0.0122	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—F2—systemic lupus erythematosus	0.000127	0.0113	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.000125	0.0112	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000124	0.0111	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	0.000113	0.0101	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.000112	0.01	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.000111	0.00996	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—C3—systemic lupus erythematosus	0.000109	0.00973	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000109	0.00973	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	9.78e-05	0.00876	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	9.55e-05	0.00856	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—F2—systemic lupus erythematosus	9.54e-05	0.00854	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	9.17e-05	0.00821	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	9.17e-05	0.00821	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	9.12e-05	0.00817	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	8.55e-05	0.00766	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCL2—systemic lupus erythematosus	8.5e-05	0.00762	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	8.39e-05	0.00751	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CXCL12—systemic lupus erythematosus	8.33e-05	0.00746	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—P2RY12—systemic lupus erythematosus	8.28e-05	0.00742	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	7.77e-05	0.00696	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TLR9—systemic lupus erythematosus	7.55e-05	0.00676	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	7.48e-05	0.0067	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCR5—systemic lupus erythematosus	7.44e-05	0.00667	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—P2RY12—systemic lupus erythematosus	7.31e-05	0.00655	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—C3—systemic lupus erythematosus	7.27e-05	0.00652	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	6.9e-05	0.00618	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CSK—systemic lupus erythematosus	6.73e-05	0.00603	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—JAK1—systemic lupus erythematosus	6.63e-05	0.00594	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—F2—systemic lupus erythematosus	6.39e-05	0.00572	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CCR5—systemic lupus erythematosus	6.28e-05	0.00563	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	6.19e-05	0.00555	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NCF2—systemic lupus erythematosus	6.15e-05	0.00551	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—C3—systemic lupus erythematosus	6.14e-05	0.0055	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	6.14e-05	0.0055	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—LYN—systemic lupus erythematosus	6.11e-05	0.00547	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—JAK1—systemic lupus erythematosus	6.02e-05	0.00539	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SH2B3—systemic lupus erythematosus	6e-05	0.00537	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	5.72e-05	0.00513	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCR5—systemic lupus erythematosus	5.71e-05	0.00511	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CCL2—systemic lupus erythematosus	5.69e-05	0.0051	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL2RA—systemic lupus erythematosus	5.62e-05	0.00504	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—C3—systemic lupus erythematosus	5.58e-05	0.00499	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL12—systemic lupus erythematosus	5.57e-05	0.00499	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—F2—systemic lupus erythematosus	5.39e-05	0.00483	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	5.2e-05	0.00466	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TLR9—systemic lupus erythematosus	5.05e-05	0.00453	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL12—systemic lupus erythematosus	4.92e-05	0.00441	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—F2—systemic lupus erythematosus	4.9e-05	0.00439	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—P2RY12—systemic lupus erythematosus	4.89e-05	0.00438	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—JUNB—systemic lupus erythematosus	4.83e-05	0.00432	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	4.62e-05	0.00414	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	4.59e-05	0.00411	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CSK—systemic lupus erythematosus	4.5e-05	0.00403	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	4.48e-05	0.00402	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PRL—systemic lupus erythematosus	4.45e-05	0.00398	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—JAK1—systemic lupus erythematosus	4.44e-05	0.00398	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—CCL2—systemic lupus erythematosus	4.36e-05	0.00391	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CCR5—systemic lupus erythematosus	4.21e-05	0.00377	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	4.15e-05	0.00371	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NCF2—systemic lupus erythematosus	4.12e-05	0.00369	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—C3—systemic lupus erythematosus	4.11e-05	0.00368	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—LYN—systemic lupus erythematosus	4.09e-05	0.00366	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—JAK1—systemic lupus erythematosus	4.03e-05	0.00361	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SH2B3—systemic lupus erythematosus	4.01e-05	0.00359	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—TYK2—systemic lupus erythematosus	3.96e-05	0.00355	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCR5—systemic lupus erythematosus	3.82e-05	0.00342	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL2RA—systemic lupus erythematosus	3.76e-05	0.00337	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—C3—systemic lupus erythematosus	3.73e-05	0.00334	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—IL2—systemic lupus erythematosus	3.63e-05	0.00325	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—F2—systemic lupus erythematosus	3.61e-05	0.00323	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—JAK1—systemic lupus erythematosus	3.56e-05	0.00319	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCR5—systemic lupus erythematosus	3.37e-05	0.00302	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.32e-05	0.00298	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL2—systemic lupus erythematosus	3.3e-05	0.00295	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—C3—systemic lupus erythematosus	3.29e-05	0.00295	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL12—systemic lupus erythematosus	3.29e-05	0.00295	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—F2—systemic lupus erythematosus	3.28e-05	0.00294	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—JUNB—systemic lupus erythematosus	3.23e-05	0.00289	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RASGRP1—systemic lupus erythematosus	3.07e-05	0.00275	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PRL—systemic lupus erythematosus	2.98e-05	0.00267	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CCL2—systemic lupus erythematosus	2.92e-05	0.00262	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—F2—systemic lupus erythematosus	2.89e-05	0.00259	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CD80—systemic lupus erythematosus	2.77e-05	0.00248	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—TYK2—systemic lupus erythematosus	2.65e-05	0.00238	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CCL2—systemic lupus erythematosus	2.58e-05	0.00231	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—IL2—systemic lupus erythematosus	2.43e-05	0.00218	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—JAK1—systemic lupus erythematosus	2.38e-05	0.00213	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TYK2—systemic lupus erythematosus	2.34e-05	0.0021	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—NOS3—systemic lupus erythematosus	2.3e-05	0.00206	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCR5—systemic lupus erythematosus	2.26e-05	0.00202	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL2RA—systemic lupus erythematosus	2.22e-05	0.00199	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL2—systemic lupus erythematosus	2.21e-05	0.00198	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—C3—systemic lupus erythematosus	2.21e-05	0.00198	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.99e-05	0.00178	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL2—systemic lupus erythematosus	1.95e-05	0.00174	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—systemic lupus erythematosus	1.94e-05	0.00174	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—F2—systemic lupus erythematosus	1.94e-05	0.00173	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CD80—systemic lupus erythematosus	1.86e-05	0.00166	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—MMP9—systemic lupus erythematosus	1.84e-05	0.00165	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.84e-05	0.00165	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—EP300—systemic lupus erythematosus	1.75e-05	0.00157	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CCL2—systemic lupus erythematosus	1.73e-05	0.00155	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.66e-05	0.00148	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TYK2—systemic lupus erythematosus	1.57e-05	0.0014	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—NOS3—systemic lupus erythematosus	1.54e-05	0.00138	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.52e-05	0.00136	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	1.33e-05	0.00119	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL2—systemic lupus erythematosus	1.3e-05	0.00117	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—systemic lupus erythematosus	1.3e-05	0.00116	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—MMP9—systemic lupus erythematosus	1.23e-05	0.00111	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.23e-05	0.0011	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—EP300—systemic lupus erythematosus	1.17e-05	0.00105	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—systemic lupus erythematosus	1.14e-05	0.00103	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.11e-05	0.000993	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.02e-05	0.000911	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—systemic lupus erythematosus	7.66e-06	0.000686	CbGpPWpGaD
